CDKN1B and lung carcinoma: In previous investigations, down-expression of P27 had been indicated in many tumor types, including lung cancer [7], hepatocellular carcinoma [8], gastric cancer [9], colorectal cancer [10] et al., which induced the progression and poor prognosis of these tumors.